Early serum tacrolimus levels predict long-term chronic kidney disease after liver transplantation

OBJECTIVE: To investigate risk factors for the development of chronic kidney disease and death two years postliver transplantation. METHOD: Associations between clinical and laboratory parameters and the development of chronic kidney disease and survival two years post-liver transplant were analyze...

Full description

Bibliographic Details
Main Authors:	Vanessa B. A. Brandão, Luciana C. Faria, Danielle M. Bicalho, Fernando H. Pereira, Agnaldo S. Lima, Teresa C. A. Ferrari
Format:	Article
Language:	English
Published:	Mavera, Edições Científicas e Técnicas Ltda
Series:	Medical Express
Subjects:	chronic kidney disease kidney dysfunction liver transplantation tacrolimus
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2358-04292014000300143&lng=en&tlng=en

Similar Items

Therapeutic drug monitoring of tacrolimus in kidney transplantation
by: Shyam Bihari Bansal
Published: (2020-01-01)

CONVERSION TO TACROLIMUS IN PATIENTS WITH LATE ACUTE AND CHRONIC REJECTION OF TRANSPLANTED KIDNEY
by: E. S. Stolyarevich, et al.
Published: (2011-06-01)

Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients
by: Son SY, et al.
Published: (2017-01-01)

Effect of tacrolimus on the results of living related kidney donor transplantation
by: V A Goriaĭnov, et al.
Published: (2014-06-01)

A case of tacrolimus-induced encephalopathy after kidney transplantation
by: Myoung Uk Kim, et al.
Published: (2011-01-01)

Relationship between 2-Hour Tacrolimus Concentrations and Clinical Outcomes in Long Term Kidney Transplantation
by: Jeffrey Yin, et al.
Published: (2020-04-01)

Safety and effectiveness of everolimus compared with sirolimus and tacrolimus in preventing kidney transplantation rejection: a systematic review and meta-analysis
by: Morteza Arab Zozani, et al.
Published: (2015-08-01)

A case report: acute pancreatitis associated with tacrolimus in kidney transplantation
by: Junnan Xu, et al.
Published: (2019-06-01)

Tacrolimus and diabetic ketoacidosis after kidney transplantation in a 15-year-old girl (Case Report)
by: Hadi Sorkhi, et al.
Published: (2016-09-01)

Basiliximab induction in living donor kidney transplant with tacrolimus-based triple immunosuppression
by: Shyam Bihari Bansal, et al.
Published: (2019-01-01)

Tacrolimus Dose Requirement in Iranian Kidney Transplant Recipients within the First Three Weeks after Transplantation
by: S Dashti-Khavidaki, et al.
Published: (2016-07-01)

HSD11B1 rs846908 polymorphisms and tacrolimus concentrations: quantum chemical analysis and implication in patients with renal transplantation
by: Beuy Joob, et al.
Published: (2017-01-01)

The Tacrolimus Metabolism Rate and Dyslipidemia after Kidney Transplantation
by: Gerold Thölking, et al.
Published: (2021-07-01)

Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation
by: Pere Fontova, et al.
Published: (2021-03-01)

Comparing the effect of immediate versus delayed initiation of tacrolimus on delayed graft function in Kidney transplant recipients: A randomized open-label clinical trial
by: Maryam Ghadimi, et al.
Published: (2018-01-01)

Drug–Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients
by: Yoshiharu Suzuki, et al.
Published: (2021-08-01)

Clinical experience of conversion from cyclosporine to tacrolimus prolonged-release in stabilized kidney transplant patients
by: Karel Krejci, et al.
Published: (2016-09-01)

Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
by: Gerold Thölking, et al.
Published: (2020-01-01)

A case of tacrolimus-induced supraventricular arrhythmia after kidney transplantation
by: Bo-Ra Kim, et al.

Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients
by: Salgado PC, et al.
Published: (2017-03-01)

Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients
by: Charat Thongprayoon, et al.
Published: (2020-07-01)

Neutrophil Gelatinase-Associated Lipocalin Is Not Associated with Tacrolimus-Induced Acute Kidney Injury in Liver Transplant Patients Who Received Mycophenolate Mofetil with Delayed Introduction of Tacrolimus
by: Mio Fukuda, et al.
Published: (2019-06-01)

The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
by: Teun van Gelder, et al.
Published: (2020-07-01)

The Impact of CYP3A5 Genotype on the Interaction Between Tacrolimus and Intravenous Nicardipine in Kidney Transplant Recipients
by: Hooper, David K.
Published: (2010)

Pregnancy outcomes after kidney transplantation
by: Sefik Gökce, et al.
Published: (2021-12-01)

Commentary: The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
by: Gerold Thölking, et al.
Published: (2021-02-01)

Tacrolimus Intra-Subject Variability in Adherent Kidney and Liver Transplant Recipients
by: Leino, Abbie D.
Published: (2018)

Conversion from Extended-Dose-Release Tacrolimus to Melt-Dose Tacrolimus in High Metabolizer Patients: Is the New Formulation of LPCT the Best Option for High Metabolizer Kidney Transplanted Patients?
by: Paolo Carta, et al.
Published: (2020-05-01)

Outcomes of Late Corticosteroid Withdrawal after Renal Transplantation in Patients Exposed to Tacrolimus and/or Mycophenolate Mofetil: Meta-Analysis of Randomized Controlled Trials
by: AK Ali, et al.
Published: (2011-10-01)

FXR activation alleviates tacrolimus-induced post-transplant diabetes mellitus by regulating renal gluconeogenesis and glucose uptake
by: Ling Li, et al.
Published: (2019-12-01)

CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
by: Chen L, et al.
Published: (2018-03-01)

Posterior reversible leukoencephalopathy syndrome (PRES) after kidney transplantation: a case report
by: Carla Beatriz Davi, et al.
Published: (2018-04-01)

Tacrolimus: Influence of the Posttransplant Concentration/Dose Ratio on Kidney Graft Function in a Two-Year Follow-Up
by: Maja Nowicka, et al.
Published: (2019-09-01)

Monitoring Tacrolimus Trough Concentrations During the First Year After Kidney Transplantation: A National Retrospective Cohort Study
by: Sarah S. Alghanem, et al.
Published: (2020-11-01)

Transplant Recipients Using Tacrolimus Had Higher Utilization of Healthcare Services Than Those Receiving Cyclosporine in Taiwan
by: Yi-Chang Lin, et al.
Published: (2019-09-01)

Increasing Time in Therapeutic Range of Tacrolimus in the First Year Predicts Better Outcomes in Living-Donor Kidney Transplantation
by: Turun Song, et al.
Published: (2019-12-01)

The relationship between tacrolimus concentration-dose ratio and genetic polymorphism in patients subjected to renal transplantation
by: Rančić Nemanja, et al.
Published: (2018-01-01)

Conversion from Twice-Daily to Once-Daily Tacrolimus Improves Graft Function but has no Influence on Proteinuria in Renal Transplant Recipients
by: Basic-Jukic Nikolina, et al.
Published: (2016-12-01)

Haemochromatosis in a kidney transplant recipient: a case report
by: Izabela Zakrocka, et al.
Published: (2021-05-01)

Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation
by: Han N, et al.
Published: (2017-11-01)